Ocuphire Pharma Price Prediction
| OCUPDelisted Stock | USD 1.13 0.06 5.04% |
Oversold Vs Overbought
39
Oversold | Overbought |
Using Ocuphire Pharma hype-based prediction, you can estimate the value of Ocuphire Pharma from the perspective of Ocuphire Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ocuphire Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ocuphire because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ocuphire Pharma after-hype prediction price | USD 1.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ocuphire |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocuphire Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ocuphire Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ocuphire Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ocuphire Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ocuphire Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ocuphire Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ocuphire Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ocuphire Pharma's historical news coverage. Ocuphire Pharma's after-hype downside and upside margins for the prediction period are 0.06 and 4.80, respectively. We have considered Ocuphire Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ocuphire Pharma is dangerous at this time. Analysis and calculation of next after-hype price of Ocuphire Pharma is based on 3 months time horizon.
Ocuphire Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ocuphire Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ocuphire Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ocuphire Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 3.67 | 0.00 | 0.01 | 6 Events / Month | 10 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.13 | 1.13 | 0.00 |
|
Ocuphire Pharma Hype Timeline
Ocuphire Pharma is now traded for 1.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Ocuphire is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at -0.12%. %. The volatility of related hype on Ocuphire Pharma is about 7864.29%, with the expected price after the next announcement by competition of 1.14. The company has price-to-book ratio of 0.86. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ocuphire Pharma recorded a loss per share of 0.54. The entity last dividend was issued on the 6th of November 2020. The firm had 1:4 split on the 6th of November 2020. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.Ocuphire Pharma Related Hype Analysis
Having access to credible news sources related to Ocuphire Pharma's direct competition is more important than ever and may enhance your ability to predict Ocuphire Pharma's future price movements. Getting to know how Ocuphire Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ocuphire Pharma may potentially react to the hype associated with one of its peers.
Ocuphire Pharma Additional Predictive Modules
Most predictive techniques to examine Ocuphire price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ocuphire using various technical indicators. When you analyze Ocuphire charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ocuphire Pharma Predictive Indicators
The successful prediction of Ocuphire Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ocuphire Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ocuphire Pharma based on analysis of Ocuphire Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ocuphire Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ocuphire Pharma's related companies.
Story Coverage note for Ocuphire Pharma
The number of cover stories for Ocuphire Pharma depends on current market conditions and Ocuphire Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ocuphire Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ocuphire Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ocuphire Pharma Short Properties
Ocuphire Pharma's future price predictability will typically decrease when Ocuphire Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ocuphire Pharma often depends not only on the future outlook of the potential Ocuphire Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ocuphire Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M | |
| Cash And Short Term Investments | 50.5 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Ocuphire Stock
If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |